BTC $78,450.53 -0.90%
ETH $2,485.98 -0.20%
BNB $749.34 +1.32%
XRP $1.43 +2.44%
SOL $103.35 -0.68%
TRX $0.3387 +1.30%
DOGE $0.0897 -0.26%
ADA $0.2214 +0.96%
BCH $257.25 -1.23%
LINK $12.61 -1.06%
HYPE $84.54 -0.56%
AAVE $129.19 -2.12%
SUI $0.8119 -1.50%
XLM $0.1889 -0.80%
ZEC $1,153.89 +0.00%
BTC $78,450.53 -0.90%
ETH $2,485.98 -0.20%
BNB $749.34 +1.32%
XRP $1.43 +2.44%
SOL $103.35 -0.68%
TRX $0.3387 +1.30%
DOGE $0.0897 -0.26%
ADA $0.2214 +0.96%
BCH $257.25 -1.23%
LINK $12.61 -1.06%
HYPE $84.54 -0.56%
AAVE $129.19 -2.12%
SUI $0.8119 -1.50%
XLM $0.1889 -0.80%
ZEC $1,153.89 +0.00%

Public company Leap Therapeutics completes $58,888,888 private placement to initiate digital asset financial strategy

2025-10-09 19:13:53

ChainCatcher news, biotechnology company Leap Therapeutics (NASDAQ: LPTX) announced that it has completed the previously announced private placement led by Winklevoss Capital, raising $58,888,888 in cash to initiate its digital asset financial strategy.

Winklevoss Capital will provide funding and strategic support to help Leap build and execute its digital asset financial strategy.

app_icon
ChainCatcher Building the Web3 world with innovations.